FIELD: organic chemistry, peptides. SUBSTANCE: product: derivatives of peptides of the formula (I): A-B-C-D-E at the definite their values. Method of inhibition of cell proliferation in human and animals involves administration of effective dose of compound of the formula (I). EFFECT: enhanced effectiveness of peptides. 11 cl, 3 tbl
| Title |
Year |
Author |
Number |
| DERIVATIVES OF PENTAPEPTIDES |
1991 |
- Jan Ehrik Paul'Sen[No]
- Karl-Ljudvig Rejkel'T[No]
|
RU2010799C1 |
| BIOTIN DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF THEIR PREPARING |
1996 |
- Al'Fred Jonchik
- Simon Goodman
- Beate Difenbakh
- Khorst Kessler
- Dirk Finzinger
|
RU2171807C2 |
| PEPTIDE DERIVATIVES OR ACID ADDITION SALTS THEREOF AND PHARMACEUTICAL COMPOSITION |
1991 |
- Andrash Balazh[Hu]
- Ishtvan Shen[Hu]
- Tamash Sirtesh[Hu]
- Lajosh Kishfaludi[Hu]
|
RU2037499C1 |
| CYCLIC AZAPEPTIDES WITH ANGIOGENIC EFFECT |
1998 |
- Jonchik Al'Fred
- Gudman Sajmon
- Kessler Khorst
- Vermut Iokhen
- Shmitt Jerg
|
RU2188205C2 |
| CYCLOHEXAPEPTIDES, MIXTURES THEREOF, AND METHOD OF PREPARING THEREOF |
1995 |
- Shtefan Khenke
- Birgit Zhordan
- Jokhen Knolle
- Leander Laufer
- Suzanne Fajertag
- Kharl-Khajnts Vismjuller
- Gjunter Jung
|
RU2163242C2 |
| MARKED PEPTIDES BINDING HEPATOCYTE GROWTH FACTOR (HGF) FOR VISUALISATION |
2008 |
- Jokhannesen Ehdvin Vil'Gel'M
- Katbertson Alan
|
RU2473361C9 |
| CYCLOPEPTIDES OF SALTS THEREOF, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS, METHOD OF PREPARING THEREOF, AND METHOD OF TREATMENT |
1993 |
- Al'Fred Jontszik
- Gjunter Khel'Tsemann
- Brunkhil'De Fel'Ding-Khabermann
- Fridrikh Rippmann
- Gvido Mel'Tser
- Beate Difenbakh
- Khorst Kessler
- Roland Khaubner
- Jokhen Vermut
|
RU2129563C1 |
| CYTOTOXIC T-CELL (CTC) INDUCING PEPTIDE, METHOD OF INDUCING CTC, ANTIBODY BOUND TO SAID PEPTIDE, USE OF SAID PEPTIDE IN PHARMACEUTICAL COMPOSITION AND FOR TREATING OR PREVENTING CANCER, ANTIGEN-PRESENTING CELL |
2006 |
- Nisikhara Tosio
- Goto Masasi
|
RU2424247C2 |
| METHOD FOR TREATING OR PREVENTING CANCER DISEASE IN INDIVIDUAL, WHICH IS CHARACTERISED BY HIGH-LEVEL EXPRESSION OR ACTIVITY OF Gadd45β (AS COMPARED TO COMMON CIVILISED CELLS) IF CANCER CELL VIABILITY AND/OR GROWTH ARE/IS STATED DEPENDENT ON NF-kB, AND TRIPEPTIDE |
2010 |
- Lou Kerolajn Minli Rejchel
- Monti Simona Marija
- Ruvo Menotti
- Tornatore Laura
- Tralo-Stjuart Keterin Dzhejn
- Frandzozo Gido
- Jaksa-Khamets Albert Andzhej
|
RU2577311C2 |
| METHODS AND COMPOSITIONS FOR CAR-T-CELL THERAPY |
2017 |
- Low, Philip Stewart
- Chu, Haiyan
- Lee, Yong Gu
|
RU2792653C2 |
